Literature DB >> 3286815

Designer drugs: past history and future prospects.

G L Henderson1.   

Abstract

Historically, drugs of abuse have come from two sources: plant products and diverted pharmaceuticals. Today, new, totally synthetic drugs produced by clandestine laboratories have become an increasingly important source of abused substances. Of particular concern are the fentanyls, a family of very potent narcotic analgesics, which first appeared on the streets in California in 1979 under the name "China White". At least 10 different analogs have been identified to date and are thought to be responsible for over 100 overdose deaths. The fentanyls are not used by any particular ethic or age group, but rather by the general heroin using population. Their use, however, does seem to be restricted to suburban, rather than urban areas, and almost exclusively to the state of California. The most potent analogs, the 3-methyl- and beta-hydroxy-fentanyls, may be up to 1000 times as potent as heroin, but are not chemically related to the opiates and therefore not detected by conventional narcotic screening tests. However, using a sensitive radioimmunoassay highly specific for the fentanyls they can be measured at the very low concentrations observed in body fluids, generally less than 10 ng/mL. It is likely that, as efforts to restrict the importation of natural products and prevent diversion of pharmaceuticals become more effective, the fentanyls and other synthetics will become increasingly important drugs of abuse.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3286815

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  25 in total

1.  Novel psychoactive substances: the rising wave of 'legal highs'.

Authors:  Farah Gilani
Journal:  Br J Gen Pract       Date:  2016-01       Impact factor: 5.386

Review 2.  Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

Authors:  Christopher L German; Annette E Fleckenstein; Glen R Hanson
Journal:  Life Sci       Date:  2013-08-02       Impact factor: 5.037

3.  An epidemic of fatal 3-methylfentanyl poisoning in Estonia.

Authors:  Ilkka Ojanperä; Merja Gergov; Milana Liiv; Aime Riikoja; Erkki Vuori
Journal:  Int J Legal Med       Date:  2008-04-03       Impact factor: 2.686

4.  Metabolism of Carfentanil, an Ultra-Potent Opioid, in Human Liver Microsomes and Human Hepatocytes by High-Resolution Mass Spectrometry.

Authors:  Michael G Feasel; Ariane Wohlfarth; John M Nilles; Shaokun Pang; Robert L Kristovich; Marilyn A Huestis
Journal:  AAPS J       Date:  2016-08-05       Impact factor: 4.009

5.  Increase in Drug Overdose Deaths Involving Fentanyl-Rhode Island, January 2012-March 2014.

Authors:  Melissa C Mercado; Steven A Sumner; M Bridget Spelke; Michele K Bohm; David E Sugerman; Christina Stanley
Journal:  Pain Med       Date:  2018-03-01       Impact factor: 3.750

6.  The effects of buprenorphine on fentanyl withdrawal in rats.

Authors:  Adrie W Bruijnzeel; Catherine Marcinkiewcz; Shani Isaac; Matthew M Booth; Donn M Dennis; Mark S Gold
Journal:  Psychopharmacology (Berl)       Date:  2007-01-09       Impact factor: 4.530

7.  The Rapidly Changing US Illicit Drug Market and the Potential for an Improved Early Warning System: Evidence from Ohio Drug Crime Labs.

Authors:  Daniel Rosenblum; Jay Unick; Daniel Ciccarone
Journal:  Drug Alcohol Depend       Date:  2020-01-07       Impact factor: 4.492

8.  Fatality due to fentanyl-cocaine intoxication resulting in a fall.

Authors:  S D Ferrara; R Snenghi; L Tedeschi
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

9.  What's in a label? Ecstasy sellers' perceptions of pill brands.

Authors:  Micheline Duterte; Camille Jacinto; Paloma Sales; Sheigla Murphy
Journal:  J Psychoactive Drugs       Date:  2009-03

Review 10.  Transdermal fentanyl: pharmacology and toxicology.

Authors:  Lewis Nelson; Robert Schwaner
Journal:  J Med Toxicol       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.